Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized mice and can protect splenectomized mice from infection with Streptococcus pneumoniae

Vaccine

Volumn 23, Issue 33, 2005, Pages 4257-4262

  Coats, Mamie T ^a   Benjamin, W H ^b   Hollingshead, S K ^a   Briles, D E ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

PspA; Splenectomy; Streptococcus pneumoniae

Indexed keywords

ANTISERUM; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; MEMBRANE PROTEIN; PROTEIN ANTIBODY; PROTEIN PSPA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; ASPLENIA; CONTROLLED STUDY; DEATH; DRUG EFFECT; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTECTION; STREPTOCOCCUS INFECTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; MICE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RECOMBINANT PROTEINS; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 22144454921     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.03.039     Document Type: Article

References (38)

1. B. Styrt Infection associated with asplenia: risks, mechanisms, and prevention Am J Med 88 5N 1990 33N 42N
2. H.R. Shinefield, C.R. Steinberg, and D. Kaye Effect of splenectomy on the susceptibility of mice inoculated with Diplococcus pneumoniae J Exp Med 123 5 1966 777 794
3. G.E. Schutze, E.O.J. Mason, W.J. Barson, K.S. Kim, E.R. Wald, and L.B. Givner Invasive pneumococcal infections in children with asplenia Pediatr Infect Dis J 21 4 2002 278 282
4. G.D. Overturf American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis Pediatrics 106 2 Part 1 2000 367 376
5. D.L. Sorrells, T.B. Morrissey, and M.F. Brown Septic complications after splenectomy for sickle cell sequestration crisis Pediatr Surg Int 13 2-3 1998 100 103
6. D.W. Wara Host defense against Streptococcus pneumoniae: the role of the spleen Rev Infect Dis 3 1981 299 309
7. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106(2 Part 1):362-6.
8. Preboth M. AAP technical report on the prevention of pneumococcal infections. American Academy of Pediatrics. Am Fam Physician 2001;63(6):1223-4, 29-30, 32.
9. M.H. Gaston, J.I. Verter, G. Woods, C. Pegelow, J. Kelleher, and G. Presbury Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial N Engl J Med 314 25 1986 1593 1599
10. C.F. Norris, S.R. Mahannah, K. Smith-Whitley, K. Ohene-Frempong, and K.L. McGowan Pneumococcal colonization in children with sickle cell disease [see comment] J Pediatr 129 6 1996 821 827
11. W.Y. Wong, G.D. Overturf, and D.R. Powars Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis, and vaccination Clin Infect Dis 14 5 1992 1124 1136
12. R.W. Steele, R. Warrier, P.J. Unkel, B.J. Foch, R.F. Howes, and S. Shah Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease J Pediatr 128 4 1996 531 535
13. V.S. Sakhalkar, S.A. Sarnaik, B.I. Asmar, R. Conner-Warren, W. Shurney, and N.M. Abdel-Haq Prevalence of penicillin-nonsusceptible Streptococcus pneumoniae in nasopharyngeal cultures from patients with sickle cell disease South Med J 94 4 2001 401 404
14. K.L. O'Brien, A.J. Swift, J.A. Winkelstein, M. Santosham, B. Stover, and R. Luddy Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease Pneumococcal Conjugate Vaccine Study Group Pediatrics 106 5 2000 965 972
15. L. Vernacchio, E.J. Neufeld, K. MacDonald, S. Kurth, S. Murakami, and C. Hohne Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease J Pediatr 133 2 1998 275 278
16. A. Brooks-Walter, D.E. Briles, and S.K. Hollingshead The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia Infect Immun 67 1999 6533 6542
17. D.E. Briles, J.D. King, M.A. Gray, L.S. McDaniel, E. Swiatlo, and K.A. Benton PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice Vaccine 14 9 1996 858 867
18. D.E. Briles, S.K. Hollingshead, J.C. Paton, E.W. Ades, L. Novak, and F.W. Van Ginkel Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae J Infect Dis 188 3 2003 339 348
19. D.E. Briles, R.C. Tart, E. Swiatlo, J.P. Dillard, P. Smith, and K.A. Benton Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA) Clin Microbiol Rev 11 4 1998 645 657
20. M. Shaper, S.K. Hollingshead, W.H. Benjamin Jr., and D.E. Briles PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin Infect Immun 72 1 2004 5031 5040
21. M. Abeyta, G.G. Hardy, and J. Yother Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae Infect Immun 71 1 2003 218 225
22. B. Ren, A.J. Szalai, O. Thomas, S.K. Hollingshead, and D.E. Briles Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae Infect Immun 71 1 2003 75 85
23. D.E. Briles, S.K. Hollingshead, J. King, A. Swift, P.A. Braun, and M.K. Park Immunization of humans with rPspA elicits antibodies, which passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA J Infect Dis 182 2000 1694 1701
24. D.E. Briles, E. Ades, J.C. Paton, J.S. Sampson, G.M. Carlone, and R.C. Huebner Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae Infect Immun 68 2 2000 796 800
25. M.L. Schulkind, E.F. Ellis, and R.T. Smith Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver Pediatr Res 1 3 1967 178 184
26. L.S. McDaniel, W.H. Benjamin Jr., C. Forman, and D.E. Briles Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia J Immunol 133 6 1984 3308 3312
27. D.E. Briles, C. Forman, J.C. Horowitz, J.E. Volanakis, W.H. Benjamin Jr., and L.S. McDaniel Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens Infect Immun 57 5 1989 1457 1464
28. A. Goldstein Biostatistics: an introductory text 1964 Macmillan Co. New York
29. R.K. Zimmerman, and J.A. Ball Adult vaccinations Prim Care 28 4 2001 763 790 [chapter vi]
30. E. Castagnola, and F. Fioredda Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes Eur J Haematol 71 5 2003 319 326
31. S.J. Schrag, L. McGee, C.G. Whitney, B. Beall, A.S. Craig, and M.E. Choate Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin Antimicrob Agents Chemother 48 8 2004 3016 3023
32. D.V. Shatz, S. Romero-Steiner, C.M. Elie, P.F. Holder, and G.M. Carlone Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively J Trauma 53 6 2002 1037 1042
33. S.W. Hosea, E.J. Brown, M.I. Hamburger, and M.M. Frank Opsonic requirements for intravascular clearance after splenectomy N Engl J Med 304 5 1981 245 250
34. D.E. Briles, R.C. Tart, H.Y. Wu, B.A. Ralph, M.W. Russell, and L.S. McDaniel Systemic and mucosal protective immunity to pneumococcal surface protein A Ann NY Acad Sci 797 1996 118 126
35. C. Wortham, L. Grinberg, D.C. Kaslow, D.E. Briles, L.S. McDaniel, and A. Lees Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2 Infect Immun 66 4 1998 1513 1520
36. H.Y. Wu, M.H. Nahm, Y. Guo, M.W. Russell, and D.E. Briles Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae J Infect Dis 175 4 1997 839 846
37. D.E. Briles, G.S. Nabors, A. Brooks-Walter, J. Paton, and C.S. Hollingshead The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae Vaccine 19 2001 S87 S95
38. H. Roche, A. Hakansson, S.K. Hollingshead, and D.E. Briles Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model Infect Immun 71 3 2003 1033 1041